Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia

Summary

Comparison of the efficacy and safety of Cresnon® and Crestor® in patients with hyperlipidemia \- 8-week, active-controlled, open-label, randomized, parallelgroup, fixed-dose, noninferiority, multicenter, phase 4 design

Timeline

Start

2014-09

Primary completion

2015-06

Completion

—

Drugs

Indications